- Early detection of lung cancer using a panel of circulating cell-free DNA methylation biomarkersHu, Shuo; Tao, Jinsheng; Peng, Minhua; Wang, Bo; Ye, Zhujia; Chen, Zhiwei; Chen, Haisheng; Yu, Haifeng; Fan, Jianbing; Bin NiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancerP. Sitthideatphaiboon; S. Santisukwongchote; S. Khunsri; C. Sathitruangsak; P. Chantranuwat; C. Vinayanuwattikun; V. SriuranpongClinical and Translational Oncology, 2020, 22(11).
- Methylation of 14-3-3 sigma gene and prognostic significance of 14-3-3 sigma expression in non-small cell lung cancerRaungrut Pritsana; Petjaroen Pingpond; Geater Sarayut Lucien; Keeratichananont Warangkana; Phukaoloun Monlika; Suwiwat Supaporn; Thongsuksai ParameeOncology Letters, 2017, 14(5): 5257-5264.
期刊论文
KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.
17阅读
